Cost-effectiveness of whole-body PET imaging in non-small cell lung cancer and malignant melanoma.
?
['Carcinoma, Non-Small-Cell Lung/diagnostic imaging/*economics', 'Cost-Benefit Analysis', 'Humans', 'Lung Neoplasms/diagnostic imaging/*economics', 'Melanoma/diagnostic imaging/*economics/secondary', 'Switzerland', 'Tomography, Emission-Computed/*economics', 'Tomography, X-Ray Computed/economics']